LIXISENATIDE — all Canadian products
3 DINs
0 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is LIXISENATIDE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02464276 | ADLYXINE | SANOFI-AVENTIS CANADA INC | Solution | Subcutaneous | LIXISENATIDE 10 MCG | Cancelled Post Market | |
| 02464284 | ADLYXINE | SANOFI-AVENTIS CANADA INC | Solution | Subcutaneous | LIXISENATIDE 20 MCG | Cancelled Post Market | |
| 02464349 | ADLYXINE | SANOFI-AVENTIS CANADA INC | Solution; Kit | Subcutaneous | LIXISENATIDE 0.05 MG; LIXISENATIDE 0.1 MG | Cancelled Post Market |
Browse other molecules: